What Is Biological Age, and Why It Matters More Than the Number on Your Licence

KEY TAKEAWAYS

• Biological age estimates the cumulative rate of damage in your tissues. Chronological age estimates how many birthdays you have had. The two are not the same.
• The most validated biological age measures are second-generation epigenetic clocks (PhenoAge, GrimAge) and pace-of-aging clocks (DunedinPACE). All correlate with mortality more strongly than chronological age.
• Modifiable inputs (sleep, glucose regulation, VO2 max, visceral adiposity, inflammatory markers) drive most of the gap between the two ages.
• Biological age is not destiny. It is feedback.

The average 52-year-old in the United States carries a biological age 4.7 years older than their chronological age, according to PhenoAge data published by Levine and colleagues (2018). For some the gap is closer to 10. For others it runs in the opposite direction. The licence tracks one variable: the rotation of the Earth around the sun since you were born. Biological age tracks the variable that actually predicts when you will get sick, when you will lose function, and when you will die.

Chronological age is administrative. It tells the bank when to release your pension and the airline when to seat you in an exit row. Biological age is clinical. It is the composite output of every meal, every workout, every night of sleep, every stressor, and every gene you carry, expressed as the rate at which your tissues are accumulating damage. When the literature describes biological age as the better predictor of all-cause mortality (Liu et al., 2018), it is not metaphor. It is a methodological claim with audited data behind it.

Two people born the same day in 1974 can have biological ages 15 years apart. The licence does not distinguish. Their biology does.

DEFINITION

What biological age actually is.

Biological age is defined as the estimated rate at which your tissues, cells, and molecular systems are accumulating the damage that drives age-related disease and mortality. It is calculated from biomarkers, methylation patterns, blood chemistries, or composite scores, and is expressed in years to make it comparable to chronological age.

Most people think biological age is a single test result. It is not. It is a class of estimates produced by different methodologies. PhenoAge is built on nine clinical biomarkers. GrimAge is trained on plasma proteins and smoking history. DunedinPACE measures rate of aging rather than accumulated age. They agree on direction. They disagree on the precise number. Treat the result as a signal, not a verdict.

THE PROBLEM

The mechanism behind the gap.

Chronological age is a legal fiction the body does not respect.

Aging is the progressive loss of biological function caused by accumulated cellular and molecular damage. The pace of accumulation is governed by genetics, around 25 percent of the variance in lifespan per Ruby et al. (2018), and by everything else, the remaining 75 percent. The everything else is what the licence cannot see.

Cellular damage compounds. DNA methylation patterns drift. Mitochondrial efficiency falls. Telomeres shorten. Senescent cells accumulate. Inflammatory tone rises. The hallmarks of aging, expanded from nine to twelve in the López-Otín et al. (2023) update, are the molecular substrate of the gap between the two ages.

Two factors decide where you land. The first is the rate at which you accrue damage. The second is the efficiency with which you repair it. Both are partially heritable. Both are highly responsive to inputs. A 50-year-old with a VO2 max in the 95th percentile, a fasting insulin under 5 mIU/L, and 7 hours of consolidated sleep is, on a methylation clock, often biologically younger than a 38-year-old with the inverse profile.

THE TRUTH

What the data forces us to conclude.

The science is no longer ambiguous. Biological age, when measured rigorously, predicts mortality risk, cardiovascular events, cancer incidence, and cognitive decline more accurately than chronological age across multiple validated cohorts. The Levine (2018) PhenoAge analysis found that each year of phenotypic age acceleration was associated with a 9 percent increase in all-cause mortality risk, independent of chronological age. The DunedinPACE work (Belsky et al., 2022) demonstrated that a faster pace of aging at midlife predicted worse function and higher disease risk a decade later, in a cohort tracked from age 26.

The harder truth is what the data implies for you. The licence number is fixed. The biological number is not. The 75 percent of variance attributable to non-genetic inputs means biological age is, within bounds, programmable. The question is no longer whether biological age can be moved. It is which inputs move it most efficiently in your specific physiology.

THE MISTAKE

The most common error.

The most common error is treating biological age as a one-time measurement.

A single epigenetic test is a snapshot. It tells you where you are. It does not tell you where you are going. The clinical value is in the trajectory and the response to specific interventions. A reader who tests once, gets a flattering result, and stops there has bought a number, not a tool.

The second error is conflating the methodology. Different clocks measure different things. PhenoAge weighs inflammation and metabolic dysregulation. GrimAge weighs plasma proteins and lifestyle damage. DunedinPACE weighs rate. Comparing your PhenoAge with a friend's GrimAge is comparing different instruments. The numbers are not interchangeable.

THE SIGNALS

What to look at first.

Before you test biological age formally, the signals are already in your routine bloodwork and your wearable. The thresholds below, drawn from the same biomarker literature the clocks are built on, indicate that biological age is likely accelerating relative to chronological age.

• Fasting insulin above 8 mIU/L. Higher predicts insulin resistance and metabolic age acceleration (Levine et al., 2018).
• hs-CRP above 1.0 mg/L. A marker of chronic low-grade inflammation, weighted heavily in PhenoAge.
• HbA1c above 5.4 percent. Above this threshold, glycation damage compounds.
• VO2 max below 35 ml/kg/min in men aged 40 to 60, below 30 ml/kg/min in women in the same range. The strongest mortality predictor in the cardiorespiratory literature (Mandsager et al., 2018).
• Resting heart rate trending up over 90 days, on Whoop or Oura, with no training stimulus to explain it.
• HRV trending down over the same window, same caveat.
• Visceral fat above 100 cm² on DEXA. Subcutaneous fat is metabolically inert. Visceral fat is metabolically loud.

Any one of these in isolation is noise. Three or more together is signal.

WHAT TO DO

The protocol.

The protocol is unglamorous and well-established. The intervention space that moves biological age is the intervention space that moves the underlying biomarkers.

• Build cardiorespiratory fitness above the 75th percentile for your age and sex. The mortality curve flattens above this threshold (Mandsager et al., 2018). Zone 2 work four times per week, with one VO2 max session, is the standard prescription.
• Restore glucose regulation. Fasting insulin under 6 mIU/L. HbA1c under 5.4 percent. Reduce refined carbohydrate intake until the numbers move. Do not start with supplements.
• Sleep 7 to 8 hours, with consolidated architecture. A wearable will tell you the duration. Time-stamped consistency tells you the architecture.
• Resistance train twice weekly, minimum. Sarcopenia is the silent driver of late-life biological age acceleration.
• Measure quarterly. Trends matter more than any single value.

THE REWIND SYSTEM LAYER

How Rewind closes the loop.

The Rewind system is built for this loop. Your protocol begins with a comprehensive baseline of the biomarkers above, integrated with your wearable data and validated against your stated objectives. The protocol adapts as the inputs change. The AI Coach inside the Rewind OS surfaces the specific lever most likely to move your biological age in your specific physiology, drawing on the same biomarker literature cited throughout this article. The work is detection, then personalisation, then adaptation. Then repeat.

MEASURE YOUR BASELINE

Measure your baseline. Begin with a Rewind biomarker panel and see where your biological age sits today: https://rewind.life

FAQ

Frequently asked questions.

Is biological age the same as epigenetic age?

Not exactly. Epigenetic age is one method of estimating biological age, based on DNA methylation. PhenoAge and GrimAge are epigenetic clocks. Phenotypic clocks built on blood chemistry are biological age estimates that are not epigenetic.

How accurate are biological age tests?

Validated second-generation clocks predict mortality and disease risk more accurately than chronological age in published cohorts. Any one result for any one individual carries an error margin of 2 to 4 years. Treat the trend across repeated tests as the signal.

Can you reverse biological age?

Within bounds, yes. Intervention studies have shown reductions of 1 to 3 years in epigenetic age over 6 to 12 months in response to lifestyle protocols (Fitzgerald et al., 2021). The effect is modest, real, and dose-dependent.

What is the best way to lower biological age?

The interventions with the largest effect sizes are the unglamorous ones. Cardiorespiratory fitness above the 75th percentile, fasting insulin under 6 mIU/L, consolidated sleep, regular resistance training, and visceral fat under 100 cm² move the biomarkers the clocks are built on.

How often should you test biological age?

Every 3 to 6 months, if at all. More frequent adds noise. Less frequent misses the trajectory.

REWIND INSIGHT

In the GrimAge validation cohorts published by Lu and colleagues (2019), each year of GrimAge acceleration was associated with significantly elevated all-cause mortality risk, with effect sizes consistently exceeding those of first-generation epigenetic clocks across multiple independent samples (combined n above 6,000). The clinical implication for the Rewind protocol: the biomarkers GrimAge integrates, chronic inflammation, glucose regulation, lipid composition, and plasma protein signatures of cumulative damage, are the same biomarkers that drive your quarterly review. Move those, and you move the metric the strongest validation cohort to date says matters most.

THE NEXT STEP

The licence is administrative. The number that earns you discounts at the cinema is not the number that determines whether you will be on a hike at 75 or in a hospital bed. Biological age is the variable you can move. It is also the variable that responds, when you give it the right inputs.

Most readers will close this article and return to whatever they were doing. A smaller number will recognise that the gap between knowing and measuring is the gap between hoping and operating. The science is settled enough to act on. The infrastructure is, finally, settled too.

Begin a Rewind baseline panel. See the number. Run the protocol. Re-test. The cycle shifts the trajectory, and the trajectory shifts the outcome.

https://rewind.life

Rewind is a membership-based longevity platform. Individual outcomes vary.

REFERENCES

Belsky, D. W., Caspi, A., Corcoran, D. L., Sugden, K., Poulton, R., Arseneault, L., Baccarelli, A., et al. (2022). DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife, 11, e73420. https://doi.org/10.7554/eLife.73420

Fitzgerald, K. N., Hodges, R., Hanes, D., Stack, E., Cheishvili, D., Szyf, M., Henkel, J., et al. (2021). Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging, 13(7), 9419 to 9432. https://doi.org/10.18632/aging.202913

Levine, M. E., Lu, A. T., Quach, A., Chen, B. H., Assimes, T. L., Bandinelli, S., Hou, L., et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging, 10(4), 573 to 591. https://doi.org/10.18632/aging.101414

Liu, Z., Kuo, P. L., Horvath, S., Crimmins, E., Ferrucci, L., & Levine, M. (2018). A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLoS Medicine, 15(12), e1002718. https://doi.org/10.1371/journal.pmed.1002718

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023). Hallmarks of aging: an expanding universe. Cell, 186(2), 243 to 278. https://doi.org/10.1016/j.cell.2022.11.001

Lu, A. T., Quach, A., Wilson, J. G., Reiner, A. P., Aviv, A., Raj, K., Hou, L., et al. (2019). DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging, 11(2), 303 to 327. https://doi.org/10.18632/aging.101684

Mandsager, K., Harb, S., Cremer, P., Phelan, D., Nissen, S. E., & Jaber, W. (2018). Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Network Open, 1(6), e183605. https://doi.org/10.1001/jamanetworkopen.2018.3605

Ruby, J. G., Wright, K. M., Rand, K. A., Kermany, A., Noto, K., Curtis, D., Varner, N., et al. (2018). Estimates of the heritability of human longevity are substantially inflated due to assortative mating. Genetics, 210(3), 1109 to 1124. https://doi.org/10.1534/genetics.118.301613

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your health regimen.

Rewind Research · Rewind Health · rewind.life · Live measured · Live longer